Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
As GLP-1 receptor agonists move beyond blood sugar and weight loss, a new review shows why clinicians must pair their growing promise with sharper monitoring, safer prescribing, and fairer access
Albiglutide was associated with fewer hypoglycemic events and moderate weight loss, but Albiglutide based on fusion protein technology produced more antibodies due to its functional protein domain
CrossRef Hepatocellular carcinoma: modern aspects of interdisciplinary management
Li HN, Zhang HM, Li XR, Wang J, Xu T, Li SY, et al
Its also important to monitor for signs of hypoglycemia or low blood sugar levels, which can cause dizziness or confusion, especially in patients with diabetes
US$ 29.81
US$ 26.33
US$ 21.15
.webp)
